Navigation Links
Dysfunction of Vocal Cord Often Misdiagnosed for Asthma

A recent investigation reveals that vocal cord dysfunction is often wrongly diagnosed as asthma.

Dr. Miles M. Weinberger, of the University of Iowa,// and his colleagues carried out this study on 49 patients who were reported to be suffering from this dysfunction from 1989 to 2002. Of the 49 patients, 41 were reported to be suffering from asthma who were of the age group 8 – 25 years. According to the study, asthma co-existed as a condition in just 12 patients!

The study reveals that vocal cord dysfunction is of two types; one in which exertion causes the symptoms while the other type is the one in which asthma symptoms occur spontaneously. Of the 49 patients, 29 were found to be suffering from the former type of vocal cord dysfunction while 20 of them from the latter type.

Weinberger tells Reuters Health, "The long-term outcome for both...types of vocal cord dysfunction was good regardless of treatment, although instruction by a speech pathologist familiar with the disorder was generally effective in providing relief for those who accepted the recommendation to pursue the treatment."

This study is cited in "Annals of Allergy, Asthma, and Immunology."


'"/>




Page: 1

Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
3. Control of anger disorder connected to Brain Dysfunction
4. An Exploration into Erectile Dysfunction in Diabetics
5. Epilepsy Medicine May Result In Sexual Dysfunction
6. Dysfunctional Families Affect The Mental Health Of The Child
7. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
8. Cardiovascular Disease More Common Among Erectile Dysfunction Patients
9. Erectile Dysfunction Connected To Heart Disease
10. Statins For Erectile Dysfunction- An Alternative To Viagra?
11. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... ... August 17, 2017 , ... Tanya Atagi, MD, is excited to announce ... Atagi Plastic Surgery and Skin Aesthetics. , To tighten skin on the face, ... ultrasound energy. Smoother, younger-looking skin is revealed on all other areas of the body ...
(Date:8/17/2017)... CO (PRWEB) , ... August 17, 2017 , ... ... Moral Injury: The Journey to Healing Through Forgiveness ($15.99, paperback, 9781498497626; $7.99, ... (war) trauma, to encourage inner healing of memories and achieve forgiveness, through a ...
(Date:8/17/2017)... , ... August 17, 2017 , ... Pot Valet is ... service growing to every city in the state, and soon, every state in the ... their need to visit a cannabis dispensary altogether. , According to Pot ...
(Date:8/17/2017)... , ... August 17, 2017 , ... Centrifugation is more ... in the laboratory that we can no longer do without. And just like a ... of your device. , In this webinar, attendees will learn about the most important ...
(Date:8/17/2017)... Seattle, WA and Lighthouse Point, FL (PRWEB) , ... ... ... Seattle-based healthcare technology firm and Cancer Center Business Development Group, a Florida-based oncology ... that examined patient care data to quantify the dollar amount of attributable savings ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... LOVELAND, Colo. , July 26, 2017 ... Tristan Guttridge and the Bimini SharkLab to custom design the ... diagnostic images of sharks in their native habitat. In ... for Discovery Channel,s Shark Week, Dr. Guttridge approached ... to take pregnancy diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology: